PT3433257T - Análogos nucleosídeos de alquinil como inibidores do rinovírus humano - Google Patents
Análogos nucleosídeos de alquinil como inibidores do rinovírus humanoInfo
- Publication number
- PT3433257T PT3433257T PT177143005T PT17714300T PT3433257T PT 3433257 T PT3433257 T PT 3433257T PT 177143005 T PT177143005 T PT 177143005T PT 17714300 T PT17714300 T PT 17714300T PT 3433257 T PT3433257 T PT 3433257T
- Authority
- PT
- Portugal
- Prior art keywords
- inhibitors
- nucleoside analogs
- human rhinovirus
- alkynyl nucleoside
- alkynyl
- Prior art date
Links
- -1 Alkynyl nucleoside Chemical class 0.000 title 1
- 241000430519 Human rhinovirus sp. Species 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000002777 nucleoside Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201602360R | 2016-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3433257T true PT3433257T (pt) | 2023-11-29 |
Family
ID=58448587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT177143005T PT3433257T (pt) | 2016-03-24 | 2017-03-21 | Análogos nucleosídeos de alquinil como inibidores do rinovírus humano |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9988416B2 (pt) |
| EP (2) | EP3433257B1 (pt) |
| JP (1) | JP7005508B2 (pt) |
| CN (1) | CN109311885A (pt) |
| AR (1) | AR107974A1 (pt) |
| DK (1) | DK3433257T3 (pt) |
| ES (1) | ES2962269T3 (pt) |
| FI (1) | FI3433257T3 (pt) |
| PL (1) | PL3433257T3 (pt) |
| PT (1) | PT3433257T (pt) |
| TW (1) | TWI746532B (pt) |
| UY (1) | UY37166A (pt) |
| WO (1) | WO2017163186A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9988416B2 (en) * | 2016-03-24 | 2018-06-05 | Novartis Ag | Alkynyl nucleoside analogs as inhibitors of human rhinovirus |
| US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
| AU2024261019A1 (en) * | 2023-04-28 | 2025-11-13 | The Scripps Research Institute | 4'-substituted nucleosides and nucleotides as antiviral agents |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0090505B1 (en) | 1982-03-03 | 1990-08-08 | Genentech, Inc. | Human antithrombin iii, dna sequences therefor, expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby, a process for expressing human antithrombin iii, and pharmaceutical compositions comprising it |
| ES2308787T3 (es) | 1996-08-16 | 2008-12-01 | Schering Corporation | Antigenos de superficie de celular de mamiferos; reactivos relacionados. |
| US6111090A (en) | 1996-08-16 | 2000-08-29 | Schering Corporation | Mammalian cell surface antigens; related reagents |
| BR9714349A (pt) | 1996-10-16 | 2000-11-14 | Icn Pharmaceuticals | L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos |
| JP2001520039A (ja) | 1997-10-21 | 2001-10-30 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ヒト腫瘍壊死因子レセプター様タンパク質、ｔｒ１１，ｔｒ１１ｓｖ１およびｔｒ１１ｓｖ２ |
| AU2591599A (en) | 1998-02-09 | 1999-08-23 | Genentech Inc. | Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| WO2001003720A2 (en) | 1999-07-12 | 2001-01-18 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| SK286630B6 (sk) | 2001-01-22 | 2009-02-05 | Merck & Co., Inc. | Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie |
| CN101899114A (zh) | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| US20040229839A1 (en) | 2003-05-14 | 2004-11-18 | Biocryst Pharmaceuticals, Inc. | Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| US7618632B2 (en) | 2003-05-23 | 2009-11-17 | Wyeth | Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies |
| WO2005007190A1 (en) | 2003-07-11 | 2005-01-27 | Schering Corporation | Agonists or antagonists of the clucocorticoid-induced tumour necrosis factor receptor (gitr) or its ligand for the treatment of immune disorders, infections and cancer |
| WO2005055808A2 (en) | 2003-12-02 | 2005-06-23 | Genzyme Corporation | Compositions and methods to diagnose and treat lung cancer |
| GB0409799D0 (en) | 2004-04-30 | 2004-06-09 | Isis Innovation | Method of generating improved immune response |
| US20060002932A1 (en) | 2004-06-04 | 2006-01-05 | Duke University | Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity |
| PT2343320T (pt) | 2005-03-25 | 2018-01-23 | Gitr Inc | Anticorpos anti-gitr e as suas utilizações |
| DK2439273T3 (da) | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| PT1907424E (pt) | 2005-07-01 | 2015-10-09 | Squibb & Sons Llc | Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1) |
| WO2007133822A1 (en) | 2006-01-19 | 2007-11-22 | Genzyme Corporation | Gitr antibodies for the treatment of cancer |
| BR122017025062B8 (pt) | 2007-06-18 | 2021-07-27 | Merck Sharp & Dohme | anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento |
| US8591886B2 (en) | 2007-07-12 | 2013-11-26 | Gitr, Inc. | Combination therapies employing GITR binding molecules |
| CN101970499B (zh) | 2008-02-11 | 2014-12-31 | 治疗科技公司 | 用于肿瘤治疗的单克隆抗体 |
| EP2262837A4 (en) | 2008-03-12 | 2011-04-06 | Merck Sharp & Dohme | PD-1 BINDING PROTEINS |
| NZ590667A (en) | 2008-07-02 | 2013-01-25 | Emergent Product Dev Seattle | Tgf-b antagonist multi-target binding proteins |
| AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
| JP2012500855A (ja) | 2008-08-25 | 2012-01-12 | アンプリミューン、インコーポレーテッド | Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法 |
| AU2009288730B2 (en) | 2008-08-25 | 2013-06-20 | Amplimmune, Inc. | Compositions of PD-1 antagonists and methods of use |
| CN102149820B (zh) | 2008-09-12 | 2014-07-23 | 国立大学法人三重大学 | 能够表达外源gitr配体的细胞 |
| EP3255060A1 (en) | 2008-12-09 | 2017-12-13 | F. Hoffmann-La Roche AG | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| AU2009329872B2 (en) | 2008-12-23 | 2016-07-07 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
| JP5844159B2 (ja) | 2009-02-09 | 2016-01-13 | ユニヴェルシテ デクス−マルセイユＵｎｉｖｅｒｓｉｔｅ Ｄ’Ａｉｘ−Ｍａｒｓｅｉｌｌｅ | Ｐｄ−１抗体およびｐｄ−ｌ１抗体ならびにその使用 |
| JP2012521359A (ja) | 2009-03-20 | 2012-09-13 | アリオス バイオファーマ インク． | 置換されたヌクレオシドアナログおよびヌクレオチドアナログ |
| KR101790802B1 (ko) | 2009-09-03 | 2017-10-27 | 머크 샤프 앤드 돔 코포레이션 | 항-ｇｉｔｒ 항체 |
| GB0919054D0 (en) | 2009-10-30 | 2009-12-16 | Isis Innovation | Treatment of obesity |
| WO2011066342A2 (en) | 2009-11-24 | 2011-06-03 | Amplimmune, Inc. | Simultaneous inhibition of pd-l1/pd-l2 |
| CA2785907A1 (en) | 2009-12-29 | 2011-07-28 | Emergent Product Development Seattle, Llc | Ron binding constructs and methods of use thereof |
| US9198972B2 (en) | 2010-01-28 | 2015-12-01 | Alnylam Pharmaceuticals, Inc. | Monomers and oligonucleotides comprising cycloaddition adduct(s) |
| AU2011282241B2 (en) | 2010-07-19 | 2015-07-30 | Gilead Sciences, Inc. | Methods for the preparation of diasteromerically pure phosphoramidate prodrugs |
| EP2619215B1 (en) | 2010-09-22 | 2018-09-05 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| WO2013039954A1 (en) | 2011-09-14 | 2013-03-21 | Sanofi | Anti-gitr antibodies |
| KR101764096B1 (ko) | 2011-11-28 | 2017-08-02 | 메르크 파텐트 게엠베하 | 항-ｐｄ-ｌ1 항체 및 그의 용도 |
| UY34887A (es) | 2012-07-02 | 2013-12-31 | Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware | Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos |
| BR112015014457A2 (pt) | 2012-12-21 | 2017-11-21 | Alios Biopharma Inc | composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c |
| AU2014302711A1 (en) | 2013-06-26 | 2015-12-10 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| WO2015054465A1 (en) * | 2013-10-11 | 2015-04-16 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| HUE051986T2 (hu) * | 2014-06-24 | 2021-04-28 | Janssen Biopharma Inc | Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra |
| US9988416B2 (en) * | 2016-03-24 | 2018-06-05 | Novartis Ag | Alkynyl nucleoside analogs as inhibitors of human rhinovirus |
-
2017
- 2017-03-21 US US15/465,485 patent/US9988416B2/en active Active
- 2017-03-21 CN CN201780031987.5A patent/CN109311885A/zh active Pending
- 2017-03-21 WO PCT/IB2017/051638 patent/WO2017163186A1/en not_active Ceased
- 2017-03-21 ES ES17714300T patent/ES2962269T3/es active Active
- 2017-03-21 FI FIEP17714300.5T patent/FI3433257T3/fi active
- 2017-03-21 PL PL17714300.5T patent/PL3433257T3/pl unknown
- 2017-03-21 PT PT177143005T patent/PT3433257T/pt unknown
- 2017-03-21 EP EP17714300.5A patent/EP3433257B1/en active Active
- 2017-03-21 JP JP2018549854A patent/JP7005508B2/ja active Active
- 2017-03-21 EP EP23202131.1A patent/EP4292658A3/en active Pending
- 2017-03-21 DK DK17714300.5T patent/DK3433257T3/da active
- 2017-03-23 AR ARP170100737A patent/AR107974A1/es unknown
- 2017-03-23 UY UY0001037166A patent/UY37166A/es not_active Application Discontinuation
- 2017-03-23 TW TW106109704A patent/TWI746532B/zh active
-
2018
- 2018-05-08 US US15/974,469 patent/US10428105B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4292658A3 (en) | 2024-03-06 |
| US20180258129A1 (en) | 2018-09-13 |
| US20170275329A1 (en) | 2017-09-28 |
| DK3433257T3 (da) | 2024-01-02 |
| UY37166A (es) | 2017-10-31 |
| JP7005508B2 (ja) | 2022-01-21 |
| ES2962269T3 (es) | 2024-03-18 |
| TWI746532B (zh) | 2021-11-21 |
| CN109311885A (zh) | 2019-02-05 |
| US10428105B2 (en) | 2019-10-01 |
| EP3433257B1 (en) | 2023-10-11 |
| TW201736391A (zh) | 2017-10-16 |
| EP4292658A2 (en) | 2023-12-20 |
| JP2019509316A (ja) | 2019-04-04 |
| PL3433257T3 (pl) | 2024-02-12 |
| AR107974A1 (es) | 2018-07-04 |
| US9988416B2 (en) | 2018-06-05 |
| EP3433257A1 (en) | 2019-01-30 |
| FI3433257T3 (fi) | 2024-01-08 |
| WO2017163186A1 (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288519A (en) | inhibitors of ret | |
| IL259794A (en) | Bicyclic inhibitors for pad4 | |
| IL253945A0 (en) | kdm1a inhibitors to treat the disease | |
| IL259281B (en) | History of bipyrazolyl used in the treatment of autoimmune diseases | |
| IL259796A (en) | Aza-benzimidazole inhibitors of pad4 | |
| IL257061A (en) | Inhibitors of ezh2 | |
| GB201402680D0 (en) | Delay coordinate analysis of physiological data | |
| GB201410646D0 (en) | Methods of increasing sequencing accuracy | |
| IL249938B (en) | Preparations of antiviral substances for preventive treatment | |
| IL254266A0 (en) | Glucosylceramide synthase inhibitors for the treatment of diseases | |
| GB201521059D0 (en) | Inhibitors of metallo-beta-lactamases | |
| EP3355890A4 (en) | HUMAN PLASMA CALLICINE REMEDY | |
| GB201708457D0 (en) | Inhibitors of metallo-beta-lactamases | |
| ZA201705847B (en) | Treatment of pain | |
| PT3433257T (pt) | Análogos nucleosídeos de alquinil como inibidores do rinovírus humano | |
| EP3193904A4 (en) | Dipeptidomimetics as inhibitors of human immunoproteasomes | |
| IL250846A0 (en) | Synthesis of cyclocreatin and its analogs | |
| GB201708451D0 (en) | Inhibitors of metallo-beta-lactamases | |
| IL263514A (en) | Using lyso-gb1 as a drug target | |
| HUE049392T2 (hu) | Paroxizmális súlyos fájdalom kezelése | |
| GB201514909D0 (en) | Treatment of autoimmune diseases |